One in Five American Adults Say They’ve Tried Hemp-Derived Products, Study Shows

More than one-fifth of American adults reported using hemp-derived cannabinoids such as cannabidiol (CBD) and delta-8 tetrahydrocannabinol (THC) in a survey of responses collected last week. -day.

The researchers not only determined the extent of how popular hemp products are, but emphasized that states that ban cannabis lead to a higher rate of delta-8 THC use perhaps because that all people can get legal in those states.

The study, Past-Year Use Prevalence of Cannabidiol, Cannabigerol, Cannabinol, and 8-Tetrahydrocannabinol Among US Adults, was published Dec. 13 in Journal of the American Medical Association (JAMA) and reference data gathered in a 2019 Gallup poll.

According to the new findings, 25.2% of adults reported past-year use of any emerging hemp-derived cannabinoid, including delta-8 THC, CBD, cannabigerol (CBG), cannabinol (CBN) , etc. Of those, 21% of adults said they used CBD specifically. Other hemp-derived products had lower rates of use: 11.9% of survey respondents reported using delta-8 THC, 5.2% reported using CBG, and 4.4% reported using which uses CBNisa in less significant cannabinoids.

The study was written by doctors Adrianne R. Wilson-Poe, Tristin Smith, Michael R. Elliott, Daniel J. Kruger, and Kevin F. Boehnke. We provide the first estimates, to our knowledge, of the prevalence of CBN, 8-THC, and CBG use last year in the US. A Gallup poll reported that 14% of US adults had personally used CBD in 2019; our reported 21% prevalence of CBD use represents a 50% increase over the past 4 years, the researchers wrote.

The prevalence of past-year cannabis use was somewhat higher than in other studies but was similarly associated with younger age, and past-year cannabis use was also associated with use of emergent products. cannabinoids, the report continues. Higher 8-THC use in states without medical or adult use of cannabis laws suggests that cannabis prohibition may inadvertently promote 8-THC use. There are few controlled human studies with emerging cannabinoids, but surveys suggest that these products are used for sleep or pain treatment.1 and in place of other medications, including pain medications.

The researchers noted that hemp products are often psychoactive, and these are the main compounds they are concerned about.

Based on these results, we support continued public health surveillance efforts targeting emerging cannabinoids due to the lack of industry standards to protect consumers and similar pharmacology or side effects of 9- THC and its hemp-derived analogues are harmful (eg, 8-THC), which may be of particular concern for adolescents and young adults, the study reports. Study limitations include failure to assess emerging patterns of cannabinoid use (eg, dose and frequency of use) and possible sampling biases, although NORC implements best practices in recruitment based on the possibility for their AmeriSpeak panel. Our results highlight the importance of future research to better understand perceptions of safety, motivations for use, and outcomes of use of these products.

Researchers warn that the products are not regulated and could put patients at risk of adverse effects from unknown contaminants.

The 2018 Farm Bill legalized the cultivation and sale of hemp, and it created a legal loophole, allowing hemp-based products to now be sold online and at smoke shops, gas stations, and other retailers.

Medscape reports that the US Food & Drug Administration (FDA) does not regulate hemp products; therefore, no federal standards exist for testing ingredients for safety or verifying ingredients as listed on labels.

“If someone is taking one of these products to use medically, and it ends up having heavy metals and pesticides and it doesn’t have the active ingredient in it, that’s not good,” says Kevin F. Boehnke, PhD , a research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center at the University of Michigan in Ann Arbor.

Ban Leads to Use of Delta-8

In states where medical cannabis is legal, residents are 56% less likely to use delta-8 THC, while those in states where adult cannabis use is legal are 55% who were less likely to use delta-8 THC than those surveyed in states without legalization.

The findings suggest that “cannabis prohibition may inadvertently promote the use of delta-8-THC,” Boehnke and his colleagues wrote.

Alice Kuo, MD, PhD, a pediatrician and professor of internal medicine and pediatrics at the David Geffen School of Medicine at the University of California at Los Angeles, told Medscape that she has seen a significant increase in patients who say they are using products cannabinoids, and believe they are natural.

“My official response to patients who ask me for my opinion is that I don’t have enough scientific background to give an opinion: If you think it helps you and you don’t have side effects, I’m not going to tell you that Stop,” said Kuo.

The FDA has warned about delta-8 THC and similar products, which it says are products that have not been proven safe.

#American #Adults #Theyve #HempDerived #Products #Study #Shows
Image Source :

Leave a Comment